MedPath

Cyclophosphamide

These highlights do not include all the information needed to use CYCLOPHOSPHAMIDE INJECTION safely and effectively. See full prescribing information for CYCLOPHOSPHAMIDE INJECTION. CYCLOPHOSPHAMIDE injection, for intravenous use Initial U.S. Approval: 1959

Approved
Approval ID

3c1eb470-0bba-457d-94e3-b9508f0d398a

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Sep 8, 2021

Manufacturers
FDA

AuroMedics Pharma LLC

DUNS: 968961354

Products 2

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

Cyclophosphamide

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code55150-271
Application NumberNDA210735
Product Classification
M
Marketing Category
C73594
G
Generic Name
Cyclophosphamide
Product Specifications
Route of AdministrationINTRAVENOUS
Effective DateSeptember 8, 2021
FDA Product Classification

INGREDIENTS (3)

CYCLOPHOSPHAMIDEActive
Quantity: 1 g in 5 mL
Code: 8N3DW7272P
Classification: ACTIM
ANHYDROUS CITRIC ACIDInactive
Code: XF417D3PSL
Classification: IACT
ALCOHOLInactive
Code: 3K9958V90M
Classification: IACT

Cyclophosphamide

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code55150-270
Application NumberNDA210735
Product Classification
M
Marketing Category
C73594
G
Generic Name
Cyclophosphamide
Product Specifications
Route of AdministrationINTRAVENOUS
Effective DateSeptember 8, 2021
FDA Product Classification

INGREDIENTS (3)

CYCLOPHOSPHAMIDEActive
Quantity: 500 mg in 2.5 mL
Code: 8N3DW7272P
Classification: ACTIM
ANHYDROUS CITRIC ACIDInactive
Code: XF417D3PSL
Classification: IACT
ALCOHOLInactive
Code: 3K9958V90M
Classification: IACT

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

Cyclophosphamide - FDA Drug Approval Details